Intratumoral Combinatorial Administration of CD1c (BDCA-1)+ Myeloid Dendritic Tissue Plus Ipilimumab along with Lansoprazole in Combination with 4 Low-Dose Nivolumab throughout People along with Superior Reliable Tumors: Any Period IB Clinical Trial. Website: http://en.wikipedia.org/wiki/Lansoprazole